Drug recall · August 8, 2018
Potassium Citrate Extended-Release Tablets recall
Why: Failed Tablet/Capsule Specifications: Tablet breakage
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Potassium Citrate Extended-Release Tablets, USP, 15 mEq, 100-count bottles, Rx only, Manufactured for: Vensun Pharmaceuticals, Inc. Yardley, PA 19067, Manufactured by: Strides Shasun Limited, Puducherry - 605 014, India, NDC 42543-408-01.
- Lots / codes
Lot #: 9570024, Exp. Jun-2019; 9570027, 9570029, Exp. Jul-2019; 7702088A, 7702089A, Exp. Aug-2019.
- Quantity
- 11,652 bottles
- Company
- Vensun Pharmaceuticals Inc, Yardley, PA
- Distribution
- Within the United States and Puerto Rico.
- Initiated
- July 18, 2018 · Voluntary: Firm initiated
- Classified
- July 27, 2018
- Reported
- August 8, 2018
- Ended
- April 16, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Potassium citrate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.